Short term fingolimod treatment decreases soluble VIA 4 levels in MS patients


Tuzun E. , Ulusoy C. A. , Turan S., Orcen A., Yetimler B., Akbas-demir D., ...Daha Fazla

12th International Congress of Neuroimmunology (ISNI), Mainz, Almanya, 9 - 13 Kasım 2014, cilt.275, ss.228 identifier